Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave. is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.
Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave. has participated in 6 clinical trials.
Therapeutic areas: COVID-19, Covid19.
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).
Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave. has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave. has 6 clinical trials on record. Their work covers COVID-19, Covid19.
Beth Israel Deaconess Medical Center (Site 202-001), 330 Brookline Ave. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.